HAIFA, Israel and TULSA, Oklahoma, December 22, 2022 – MeMed, a leader in the emerging field of advanced host-response technologies, and Tulsa ER & Hospital, a physician-managed facility with a mission to restore the provider and patient relationship through communication and individualized treatment plans, today announce that Tulsa ER & Hospital is adopting the trailblazing MeMed BV® test that distinguishes between a bacterial and viral infection in just 15 minutes from serum.

Read more here.